Cancer predisposition syndromes: lessons for truly precision medicine.

about

Genetics meets pathology - an increasingly important relationship.The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.

P2860

Q39012198-C9A360CC-A1FF-4059-92A2-AE6E1BD6FA50 Q52330740-6FF1CD76-7EC5-487A-9832-1D84E975646E

P2860

Cancer predisposition syndromes: lessons for truly precision medicine.

Item

http://www.wikidata.org/entity/Q39012229

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cancer predisposition syndromes: lessons for truly precision medicine.

@en

Cancer predisposition syndromes: lessons for truly precision medicine.

@nl

type

Item

label

Cancer predisposition syndromes: lessons for truly precision medicine.

@en

Cancer predisposition syndromes: lessons for truly precision medicine.

@nl

prefLabel

Cancer predisposition syndromes: lessons for truly precision medicine.

@en

Cancer predisposition syndromes: lessons for truly precision medicine.

@nl

P1476

Cancer predisposition syndromes: lessons for truly precision medicine.

@en

P2093

David N Church

http://www.w3.org/2001/XMLSchema#string

Mark A Glaire

http://www.w3.org/2001/XMLSchema#string

Matthew Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

Comprehensive molecular characterization of human colon and rectal cancer

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.

Mutation of a mutL homolog in hereditary colon cancer

The ABC of APC

The 3' 5' exonucleases

P304

226-235

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4842

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

241

http://www.w3.org/2001/XMLSchema#string

P50

Ian Tomlinson

P577

2016-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27859368

http://www.w3.org/2001/XMLSchema#string

Cancer predisposition syndromes: lessons for truly precision medicine.

about

P2860

P2860

Cancer predisposition syndromes: lessons for truly precision medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698